Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Entrada Therapeutics, Inc. | StockGist | StockGist

Companies
TRDA
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings TRDASCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Entrada Therapeutics, Inc.

Filed Nov 25, 2025

Accepted Nov 24, 2025, 7:00 PM ET

CIK 0001689375

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

38,219,232

Reporting Person

Entrada Therapeutics, Inc.

Person Type

OO

CUSIP: 29384C108

Key Facts

Shares Owned

38,219,232

Recent Filings

Entrada Therapeutics, Inc.1 months ago

Entrada Therapeutics, Inc.1 months ago

Entrada Therapeutics, Inc.2 months ago

Entrada Therapeutics, Inc.4 months ago

Entrada Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice